Skip to content

3 Year Retrospective Analysis of IVF in Comparison With INVOcell

A 3 Year Retrospective Analysis of Fertility Clinic's of In Vitro Fertilization (IVF) in Comparison With INVOcell Intravaginal Culture (INVOcell IVC) Device

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05189405
Enrollment
450
Registered
2022-01-12
Start date
2021-10-12
Completion date
2022-02-28
Last updated
2022-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Retrospective chart review of data on the use of traditional IVF and INVOcell IVC collected from clinics using both technologies. The retrospective data will be utilized for a comparison of the two methods.

Detailed description

The following aspects of data will be collected to support the analysis of the two methods * Procedure details for including oil overlay and incubation time frame * Characteristics of embryo quality and phase of development and transfer rates * Clinical pregnancy rate * Live birth rate Secondary: Data regarding safety * Adverse events noted by the women that received IVF and INVOcell IVC * Adverse events noted for the offspring

Interventions

DEVICEINVOcell IVC

Embryo development in intravaginal incubation

Sponsors

INVO Bioscience, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years

Inclusion criteria

* Subjects that have received infertility treatment with either INVOcell IVC or standard IVF during the same timeframe. All subjects treated with the standard of care IVF method during the same timeframe that the center used INVOcell IVC were included in the retrospective data collection.

Exclusion criteria

* Not applicable

Design outcomes

Primary

MeasureTime frameDescription
Embryo development5 daysCharacteristics of embryo quality and phase of development and transfer rates
Clinical pregnancy rate5 daysClinical pregnancy rate
Live birth rate5 daysLive birth rate

Secondary

MeasureTime frameDescription
Maternal Adverse Events5 daysAdverse events noted by the women that received IVF and INVOcell IVC
Offspring adverse events5 daysAdverse events noted for the offspring

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026